Assessment of Augmentation Strategies to Optimize the Therapeutic Response to Mirtazapine in Major Depression.

Trial Profile

Assessment of Augmentation Strategies to Optimize the Therapeutic Response to Mirtazapine in Major Depression.

Completed
Phase of Trial: Phase III

Latest Information Update: 18 Aug 2011

At a glance

  • Drugs Bupropion; Fluoxetine; Mirtazapine; Venlafaxine
  • Indications Depressive disorders; Major depressive disorder
  • Focus Therapeutic Use
  • Sponsors Organon Pharmaceuticals USA
  • Most Recent Events

    • 10 Jun 2010 Results presented at the 27th International Congress of Collegium Internationale Neuro Psychopharmacologicum.
    • 26 Mar 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top